MAGNESIUM OXIDE- magnesium oxide tablet 
Covetrus North America

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Magnesium oxide

Wet granulation formula

Antacid - laxative

For animal use only

Keep out of reach of children

Indications:

For oral administration in cattle, sheep and goats as a aid in the treatment of digestive disturbances requiring and antacid and mild laxative.

Dosage and administration

Give 2 to 4 boluses to ruminants, depending on size and condition of animal. Lubricate boluses and administer with a balling gun.

Precaution

Avoid frequent or continued use.

TAKE TIME OBSERVE LABEL DIRECTIONS

Composition

Each bolus contains:

magnesium oxide ......................... 276 gr (17.9 g)

(Equivalent to magnesium hydroxide3, 400 gr.).

Also contains ginger (flavoring), capsicum, and methyl salicylate. Artificial color added.

One and one-half magnesium boluses are equivalent to one pint of milk of magnesia.

Store at controlled room temperature between 15° and 30°C (59°-86°F).

Keep tightly closed when not in use.

Covetrus Mag Bolus 21

MAGNESIUM OXIDE 
magnesium oxide tablet
Product Information
Product TypeOTC ANIMAL DRUGItem Code (Source)NDC:11695-4148
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MAGNESIUM OXIDE (UNII: 3A3U0GI71G) (MAGNESIUM CATION - UNII:T6V3LHY838) MAGNESIUM CATION17.9 g
Inactive Ingredients
Ingredient NameStrength
SODIUM STARCH GLYCOLATE TYPE A CORN (UNII: AG9B65PV6B)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
STARCH, CORN (UNII: O8232NY3SJ)  
WATER (UNII: 059QF0KO0R)  
Product Characteristics
ColorpinkScore2 pieces
ShapeOVALSize8mm
FlavorImprint Code 2
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:11695-4148-550 in 1 PACKAGE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other01/20/2020
Labeler - Covetrus North America (603750329)

Revised: 1/2021
Document Id: 9f5adc86-aa40-44d6-8de1-781a240ff25a
Set id: 4d68aec7-3cf8-481a-8844-13f44922bddf
Version: 2
Effective Time: 20210105
 
Covetrus North America